Connect With Us:
REPORT ID 6222

United States Hepatocyte Growth Factor Market Report 2017

Publish Date
25-Dec-17
Pages
98
Format
Electronic (PDF)

Full report description 
In this report, the United States Hepatocyte Growth Factor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Hepatocyte Growth Factor in these regions, from 2012 to 2022 (forecast).

United States Hepatocyte Growth Factor market competition by top manufacturers/players, with Hepatocyte Growth Factor sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Amgen Inc.
    AnGes MG, Inc.
    Kringle Pharma, Inc.
    M3 Biotechnology, Inc.
    Minerva Biotechnologies Corporation
    Molecular Partners AG
    ViroMed Co., Ltd.
    Yooyoung Pharmaceutical Co., Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Beperminogene Perplasmid
    FS-101
    MP-0250
    NDX-1017
    NK-4
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Coronary Arterial Disease
    Arteriosclerosis
    Colorectal Cancer
    Dementia
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of contents 
Table of Contents

United States Hepatocyte Growth Factor Market Report 2017
1 Hepatocyte Growth Factor Overview
    1.1 Product Overview and Scope of Hepatocyte Growth Factor
    1.2 Classification of Hepatocyte Growth Factor by Product Category
        1.2.1 United States Hepatocyte Growth Factor Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Hepatocyte Growth Factor Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Beperminogene Perplasmid
        1.2.4 FS-101
        1.2.5 MP-0250
        1.2.6 NDX-1017
        1.2.7 NK-4
        1.2.8 Others
    1.3 United States Hepatocyte Growth Factor Market by Application/End Users
        1.3.1 United States Hepatocyte Growth Factor Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Coronary Arterial Disease
        1.3.3 Arteriosclerosis
        1.3.4 Colorectal Cancer
        1.3.5 Dementia
        1.3.6 Others
    1.4 United States Hepatocyte Growth Factor Market by Region
        1.4.1 United States Hepatocyte Growth Factor Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Hepatocyte Growth Factor Status and Prospect (2012-2022)
        1.4.3 Southwest Hepatocyte Growth Factor Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Hepatocyte Growth Factor Status and Prospect (2012-2022)
        1.4.5 New England Hepatocyte Growth Factor Status and Prospect (2012-2022)
        1.4.6 The South Hepatocyte Growth Factor Status and Prospect (2012-2022)
        1.4.7 The Midwest Hepatocyte Growth Factor Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Hepatocyte Growth Factor (2012-2022)
        1.5.1 United States Hepatocyte Growth Factor Sales and Growth Rate (2012-2022)
        1.5.2 United States Hepatocyte Growth Factor Revenue and Growth Rate (2012-2022)

2 United States Hepatocyte Growth Factor Market Competition by Players/Suppliers
    2.1 United States Hepatocyte Growth Factor Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Hepatocyte Growth Factor Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Hepatocyte Growth Factor Average Price by Players/Suppliers (2012-2017)
    2.4 United States Hepatocyte Growth Factor Market Competitive Situation and Trends
        2.4.1 United States Hepatocyte Growth Factor Market Concentration Rate
        2.4.2 United States Hepatocyte Growth Factor Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Hepatocyte Growth Factor Manufacturing Base Distribution, Sales Area, Product Type

3 United States Hepatocyte Growth Factor Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Hepatocyte Growth Factor Sales and Market Share by Region (2012-2017)
    3.2 United States Hepatocyte Growth Factor Revenue and Market Share by Region (2012-2017)
    3.3 United States Hepatocyte Growth Factor Price by Region (2012-2017)

4 United States Hepatocyte Growth Factor Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Hepatocyte Growth Factor Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Hepatocyte Growth Factor Revenue and Market Share by Type (2012-2017)
    4.3 United States Hepatocyte Growth Factor Price by Type (2012-2017)
    4.4 United States Hepatocyte Growth Factor Sales Growth Rate by Type (2012-2017)

5 United States Hepatocyte Growth Factor Sales (Volume) by Application (2012-2017)
    5.1 United States Hepatocyte Growth Factor Sales and Market Share by Application (2012-2017)
    5.2 United States Hepatocyte Growth Factor Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Hepatocyte Growth Factor Players/Suppliers Profiles and Sales Data
    6.1 Amgen Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Hepatocyte Growth Factor Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Amgen Inc. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 AnGes MG, Inc.
        6.2.2 Hepatocyte Growth Factor Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 AnGes MG, Inc. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Kringle Pharma, Inc.
        6.3.2 Hepatocyte Growth Factor Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Kringle Pharma, Inc. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 M3 Biotechnology, Inc.
        6.4.2 Hepatocyte Growth Factor Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 M3 Biotechnology, Inc. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Minerva Biotechnologies Corporation
        6.5.2 Hepatocyte Growth Factor Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Minerva Biotechnologies Corporation Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Molecular Partners AG
        6.6.2 Hepatocyte Growth Factor Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Molecular Partners AG Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 ViroMed Co., Ltd.
        6.7.2 Hepatocyte Growth Factor Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 ViroMed Co., Ltd. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Yooyoung Pharmaceutical Co., Ltd.
        6.8.2 Hepatocyte Growth Factor Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Yooyoung Pharmaceutical Co., Ltd. Hepatocyte Growth Factor Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Hepatocyte Growth Factor Manufacturing Cost Analysis
    7.1 Hepatocyte Growth Factor Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Hepatocyte Growth Factor

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Hepatocyte Growth Factor Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Hepatocyte Growth Factor Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Hepatocyte Growth Factor Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Hepatocyte Growth Factor Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Hepatocyte Growth Factor Sales Volume Forecast by Type (2017-2022)
    11.3 United States Hepatocyte Growth Factor Sales Volume Forecast by Application (2017-2022)
    11.4 United States Hepatocyte Growth Factor Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer